Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small cysteine and glycine repeat containing protein 10 (SCYGR10) is a member of the keratin-associated protein (KRTAP) family, specifically within the subfamily of small cysteine and glycine repeat-containing proteins[1][2][4][6]. These proteins are synthesized during hair matrix cell differentiation and are involved in the formation, structure, and rigidity of hair fibers through extensive disulfide bond cross-linking with hair keratins, contributing to the mechanical strength of the hair shaft[1][4][6]. SCYGR10 and related SCYGR genes are clustered on human chromosome 2q36.3; due to allelic polymorphisms, some gene variants are non-coding, and the primary human reference genome version is non-coding for this gene[1][2]. While important for hair biology, SCYGR10 is not a recognized therapeutic target, drug receptor, enzyme, or transporter and there are no known drugs, biomarker applications, or safety profiles associated with this molecule[1][2][4][6]. In several genomic resources, the gene may be annotated as a pseudogene, indicating a lack of known functional protein expression in some alleles[1][2][4]. Key points: - **SCYGR10 is not a therapeutic target**; it is a structural keratin-associated protein involved in hair formation[1][2][4][6]. - There is **no evidence of drug interactions, biomarker use, or direct disease involvement**. - Several aliases point to its inclusion in the KRTAP family; some designations emphasize its pseudogene status[1][2][4]. - Entries using "pseudogene" or indicating the gene is non-coding for most reference alleles mean it is **not a typical protein-coding therapeutic or diagnostic target**, and its potential for drug targeting is null[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small cysteine and glycine repeat containing protein 10 (SCYGR10).